Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial

OBJECTIVE: This was a first pilot study evaluating the acute phase (8-week) efficacy of the antidepressant medication mirtazapine for the treatment of depressive symptoms and drinking of subjects with comorbid major depressive disorder and alcohol dependence (MDD/AD). We hypothesized that mirtazapin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cornelius, Jack R., Douaihy, Antoine B., Clark, Duncan B., Chung, Tammy, Wood, D. Scott, Daley, Dennis
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3516621/
https://ncbi.nlm.nih.gov/pubmed/23230395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15504263.2012.696527
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky